NCT04394325 is a NA clinical trial of Digital information tool in Breast Cancer, sponsored by Jonkoping University.

Who is sponsoring NCT04394325?

NCT04394325 is sponsored by Jonkoping University.

What drugs are being tested in NCT04394325?

Interventions in NCT04394325: Digital information tool.

What condition does NCT04394325 study?

NCT04394325 studies Breast Cancer.

Is NCT04394325 still recruiting?

NCT04394325 is currently completed. Last updated 17 December 2025.

Last reviewed 2025-12-17 · How we verify

NCT04394325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer

Completed NA Last updated 17 December 2025

What this trial tests

NA trial testing Digital information tool in Breast Cancer in 80 participants. Completed in 30 November 2023.

Timeline

1 September 2020

Primary endpoint
1 June 2022

30 November 2023

Quick facts

Lead sponsor	Jonkoping University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	80
Start date	1 September 2020
Primary completion	1 June 2022
Estimated completion	30 November 2023
Sites	1 location across Sweden

Drugs / interventions tested

Digital information tool

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Jonkoping University

Who can join

18 and older, any sex, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project uses participatory design combined with qualitative and quantitative methods to develop, explore and evaluate the usefulness of a digital information tool to prepare and support patients before, during and after RT as treatment for breast cancer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Digi-Do: a digital information tool to support patients with breast cancer before, during, and after start of radiotherapy treatment: an RCT study protocol.
Fristedt S, Smith F, Grynne A, Browall M. · · 2021 · cited 13× · PMID 33632215 · DOI 10.1186/s12911-021-01448-3
Factors associated with distress over time in women with breast cancer undergoing radiotherapy: insights from a pilot study assessing a digital information tool.
Grynne A, Fristedt S, Wiklund DB, Smith F, et al · · 2025 · PMID 40794292 · DOI 10.1007/s00520-025-09798-8

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Jonkoping University trials

Trials by the same sponsor.

NCT05791084 — Supporting Women With Breast Cancer to Practice DIBH at Home Before Radiation Therapy · NA · not yet recruiting
NCT05813197 — Leaving Care - a Comparison Study of Implementation, Change Mechanisms, and Effects of Transition Services for Youth Lea · NA · unknown
NCT05507788 — Multicell Air Cushions: Sitting Posture and Limits of Stability · NA · unknown
NCT05020977 — Physical Actitvity and Blood Pressure Among Ambulance Personnel During Work and Leisure · completed
NCT03938805 — I-CBT Tailored to Patients With Cardiovascular Disease and Insomnia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04394325 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jonkoping University
Last refreshed: 17 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04394325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing